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Leprosy and Kaposi sarcoma presenting as an immune
reconstitution inflammatory syndrome in a
patient with AIDS
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The simultaneous presence of infectious organisms within cutaneous lesions of Kaposi sarcoma in persons
with AIDS has been demonstrated. We describe a patient with concurrent leprosy and Kaposi sarcoma
presenting as an immune reconstitution inflammatory syndrome in the setting of AIDS. ( J Am Acad
Dermatol 2009;61:516-8.)CASE REPORT
We report a 46-year-old woman, born in Angola
who resided in Portugal since 1999. She had been
monitored by the infectious disease department of
our hospital since the diagnosis of HIV-1 infection in
2005. At that time she had a blood CD41 lymphocyte
count of 91 cells/mL and a plasma virus load of
37,369 HIV RNA copies/mL. Highly active antiretro-
viral therapy (HAART) (zidovudine, lamivudine, and
efavirenz) was started. After 4 months, the patient
reported the appearance of skin lesions that first
developed on her face and subsequently spread
caudally. She also reported a burning sensation in
hands and feet, nasal obstruction, and mucosal
rhinorrhea.
Cutaneous examination revealed a dimorphic
eruption. Her face and extremities showed localized
areas of multiple 0.5- to 1-cm skin-colored firm
papules (60-80 in total). Intermixed with these pap-
ules there were nodules and plaques with a bright
and smooth surface, slightly darker than normal-
appearing skin, each approximately 1 to 3 cm in
diameter (10-15 in total) (Fig 1, A). The patient also
had supraciliary madarosis, edema localized to both
hands and feet, and ichthyosiform scaling of both
legs. Many confluent, violaceous-brownish macules
with a superficial white fine scale were observed on
the soles of the feet (Fig 1,B). Therewere nomucosal
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doi:10.1016/j.jaad.2008.11.885516lesions or palpable lymphadenopathy. Neurologic
examination revealed loss of sensation to light touch
in some skin lesions, anesthesia of both legs from the
feet to the knees, and a thickened painful left ulnar
nerve. As a result, the clinical diagnosis of leprosy and
Kaposi sarcoma (KS) was suspected.
Skin and mucous bacteriological indices were
positive (41, 41) according to Ridley-Jopling classi-
fication. Histopathology of a skin biopsy specimen
from a plaque on the back of the right hand con-
firmed the diagnosis: a dense and diffuse inflamma-
tory infiltrate of lymphocytes, histiocytes (some with
cytoplasmic vacuolization), and plasmocytes extend-
ing from the papillary deeper dermis. With Fite-
Faraco stain, numerous intracellular and extracellular
bacilli were visible. The nerves were also affected by
this inflammatory process and by the presence of
multiple bacilli. In addition, we observed inter-
mingled spindle-shaped cells forming slitlike spaces,
associated with extravascular erythrocytes. Human
herpesvirus-8-associated antigens were detected in
situ by immunohistochemistry (Fig 2).
Six months after the onset of HAART the patient’s
plasma virus load was less than 50 HIV-1 RNA
copies/mL and her CD41 lymphocyte count had
increased to 283 cells/mL. Accordingly, the diagnosis
of borderline lepromatous leprosy with reversal (type-
1) reaction, associated with KS and presenting as an
immune reconstitution inflammatory syndrome (IRIS),
was confirmed. The World Health Organizatione
recommended multidrug therapy for patients with
Abbreviations used:
HAART: highly active antiretroviral therapy
IRIS: immune reconstitution inflammatory
syndrome
KS: Kaposi sarcoma
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Case reports 517multibacillary leprosy was started, and the erythema
and edema caused by the reversal reaction initially
decreased in response to additional treatment with
prednisolone (40 mg/d), with slow tapering over 4
months. KS lesions progressively regressed.
DISCUSSION
The coexistence ofmultiple entitieswithin a single
lesion is not without precedent in patients with
HIV-1.1,2 In fact, leprosy and HIV infection coexist,
mainly in Africa, Brazil, and India, and reactional
states linked to the introduction of HAART have been
recently described in 19patientswithMycobacterium
leprae andHIV coinfection (16male).3-15 Since its first
report in 2003, it has become clear that the introduc-
tion of HAART changed the natural history of leprosy
Fig 1. A, Cutaneous lesions of borderline lepromatous
leprosy (arrows) intermingled with Kaposi sarcoma le-
sions (asterisk). B, Confluent violaceous macules on soles
of feet compatible with Kaposi sarcoma.inHIV-infectedpatients.3,15 In 19 cases (including the
patient we describe) the clinical manifestations of
IRIS were leprosy type-1 reactions, some unusually
severe and associated with vasculitis and ulcerous
progression.8
Although it seems that leprosy manifesting as IRIS
is similar to leprosy type-1 reactions, in which there
is an overaction of T-helper-1 lymphocyte responses
toM leprae antigens, it is interesting to notice that the
pathomechanisms of both are different.14,15 In the
former, the primary event is restoration of immunity
by HAART, which then recognizes and mounts an
immune response against the bacilli. In contrast, in
classic type-1 leprosy reactions, there is initial lysis of
bacilli by multidrug therapy that then restores the
immune system and this reconstituted immune re-
sponse leads to a type-1 reaction.11,16 Furthermore,
all reported cases belong to the tuberculoid spec-
trum of leprosy, implying that there is a good
immune host response. This is not true for two
patients (including the current one) with borderline
lepromatous multibacillary disease; these patients
were probably anergic against mycobacteria and as
HAART increased cellular immune response, it trig-
gered reactional type-1 leprosy, instead of type-2
reactions.13
These cases may, therefore, provide indirect ev-
idence that, at least in some patients, the clinical
presentation of leprosy is suppressed by HIV-asso-
ciated advanced immunodeficiency until HAART
provides the immunologic ‘‘trigger’’ that leads to
disease presentation, in all cases within 6 months
after the introduction of HAART.8,15
An association between KS and HIV infection is
also well established.2 Nevertheless, the association
among leprosy, KS, and AIDS has only been reported
in 3 patients.2,17
The temporal association between the develop-
ment of skin lesions and changes in blood CD41
lymphocyte count and plasma HIV-1 load observed
during HAART strongly suggests that the presenta-
tion of these two conditions resulted from IRIS.
Finally, it is also important to state that if the
presentation of these 2 diseases as an IRIS can be
detected even in a low leprosy-endemic country
such as Portugal, an increase in similar cases can be
anticipated in areas where HIV and leprosy occur in
higher frequencies, especially as access to HAART
becomes more widely available.
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